These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 18220949)
1. Interleukin-21 (IL-21) controls inflammatory pathways in the gut. Fina D; Caruso R; Pallone F; Monteleone G Endocr Metab Immune Disord Drug Targets; 2007 Dec; 7(4):288-91. PubMed ID: 18220949 [TBL] [Abstract][Full Text] [Related]
2. IL-21 comes of age as a regulator of effector T cells in the gut. Fantini MC; Monteleone G; MacDonald TT Mucosal Immunol; 2008 Mar; 1(2):110-5. PubMed ID: 19079168 [TBL] [Abstract][Full Text] [Related]
3. New players in the cytokine orchestra of inflammatory bowel disease. Fantini MC; Monteleone G; Macdonald TT Inflamm Bowel Dis; 2007 Nov; 13(11):1419-23. PubMed ID: 17712836 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-21 triggers effector cell responses in the gut. De Nitto D; Sarra M; Pallone F; Monteleone G World J Gastroenterol; 2010 Aug; 16(29):3638-41. PubMed ID: 20677335 [TBL] [Abstract][Full Text] [Related]
5. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease. Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594 [TBL] [Abstract][Full Text] [Related]
7. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis. Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319 [TBL] [Abstract][Full Text] [Related]
8. Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. Serriari NE; Eoche M; Lamotte L; Lion J; Fumery M; Marcelo P; Chatelain D; Barre A; Nguyen-Khac E; Lantz O; Dupas JL; Treiner E Clin Exp Immunol; 2014 May; 176(2):266-74. PubMed ID: 24450998 [TBL] [Abstract][Full Text] [Related]
9. Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease. Fonseca-Camarillo G; Furuzawa-Carballeda J; Yamamoto-Furusho JK Cytokine; 2015 Oct; 75(2):389-402. PubMed ID: 26141420 [TBL] [Abstract][Full Text] [Related]
10. Absence of a role for interleukin-13 in inflammatory bowel disease. Biancheri P; Di Sabatino A; Ammoscato F; Facciotti F; Caprioli F; Curciarello R; Hoque SS; Ghanbari A; Joe-Njoku I; Giuffrida P; Rovedatti L; Geginat J; Corazza GR; MacDonald TT Eur J Immunol; 2014 Feb; 44(2):370-85. PubMed ID: 24338958 [TBL] [Abstract][Full Text] [Related]
11. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634 [TBL] [Abstract][Full Text] [Related]
12. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Louis E; Ribbens C; Godon A; Franchimont D; De Groote D; Hardy N; Boniver J; Belaiche J; Malaise M Clin Exp Immunol; 2000 May; 120(2):241-6. PubMed ID: 10792371 [TBL] [Abstract][Full Text] [Related]
13. Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease. Camoglio L; Te Velde AA; Tigges AJ; Das PK; Van Deventer SJ Inflamm Bowel Dis; 1998 Nov; 4(4):285-90. PubMed ID: 9836081 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut. Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427 [TBL] [Abstract][Full Text] [Related]
15. IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Mitsuyama K; Toyonaga A; Sasaki E; Watanabe K; Tateishi H; Nishiyama T; Saiki T; Ikeda H; Tsuruta O; Tanikawa K Clin Exp Immunol; 1994 Jun; 96(3):432-6. PubMed ID: 8004812 [TBL] [Abstract][Full Text] [Related]
16. NLRP3-Dependent and -Independent Processing of Interleukin (IL)-1β in Active Ulcerative Colitis. Ranson N; Veldhuis M; Mitchell B; Fanning S; Cook AL; Kunde D; Eri R Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30583612 [TBL] [Abstract][Full Text] [Related]
17. Compartmentalized expression of Th1 and Th17 cytokines in pediatric inflammatory bowel diseases. Verdier J; Begue B; Cerf-Bensussan N; Ruemmele FM Inflamm Bowel Dis; 2012 Jul; 18(7):1260-6. PubMed ID: 21994045 [TBL] [Abstract][Full Text] [Related]
18. The influence of cigarette smoking on cytokine levels in patients with inflammatory bowel disease. Sher ME; Bank S; Greenberg R; Sardinha TC; Weissman S; Bailey B; Gilliland R; Wexner SD Inflamm Bowel Dis; 1999 May; 5(2):73-8. PubMed ID: 10338374 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 production in pediatric inflammatory bowel disease: evidence for dissimilar mononuclear cell function in Crohn's disease and ulcerative colitis. Gurbindo C; Sabbah S; Menezes J; Justinich C; Marchand R; Seidman EG J Pediatr Gastroenterol Nutr; 1993 Oct; 17(3):247-54. PubMed ID: 8271122 [TBL] [Abstract][Full Text] [Related]
20. Association of T Helper 1 Cytokine Gene Single Nucleotide Polymorphisms with Ulcerative Colitis and Crohn's Disease. Ebrahimi Daryani N; Sadr M; Soltani S; Saghazadeh A; Moossavi S; Shahkarami S; Farhadi E; Rezaei N Dig Dis; 2019; 37(1):21-32. PubMed ID: 30134230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]